| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
TSHA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.91M | $13.41M | - | |
| CFO | 1.44M | $6.52M | - | |
| Dir | 1.18M | - | - | |
| Pres | 936.4K | $5.84M | - | |
| Dir | 241.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Donenberg Phillip B. | Director | Buy | 3,000 | $7.78 | $23,340.00 | New | -44.0% | -84.6% | |
| Nov 24, 2021 | Manning Paul B54 | Director, 10% Owner | Buy | 2,202 | $13.19 | $29,044.38 | +6.9% | -54.3% | -82.6% | |
| Nov 23, 2021 | Session R.A. II | President And CEO | Buy | 42,518 | $12.44 | $529,102.40 | +0.5% | -52.3% | -81.8% | |
| Nov 23, 2021 | Manning Paul B54 | Director, 10% Owner | Buy | 20,000 | $12.54 | $250,800.00 | +166.7% | -52.3% | -81.8% | |
| Aug 20, 2021 | Alam Kamran83 | Chief Financial Officer | Sell | 33,000 | $16.88 | $557,022.56 | -10.0% | -18.5% | -77.9% | |
| Jul 1, 2021 | Prasad Suyash90 | CMO And Head Of R&D | Sell | 79,000 | $22.63 | $1,787,935.64 | -11.7% | -8.9% | -83.6% | |
| May 20, 2021 | Nolan Sean P. | Director | Buy | 1,170 | $22.35 | $26,149.50 | New | -21.5% | -87.2% | |
| May 14, 2021 | Manning Paul B54 | Director, 10% Owner | Buy | 12,000 | $20.98 | $251,760.00 | New | -16.6% | -83.6% |